PD is scientifically and clinically important. This manuscript has addressed on this topic and has demonstration a significant neuroprotective effects in rotenone induced cell death model on A53T mutant SH-SY5Y cells. Moreover, this manuscript has tried to explain the mechanism about why genistein (GS) has presented such an neuroprotective effect. This is why I support this manuscript for publication.
But, there are two deficits here which I would hope to see more supporting data.
Firstly, the cellular model used here is A53T mutant α-synuclein SH-SY5Y cells. Of course, it is correct to use mutation for α-synuclein, as the latter has been widely proved in and tightly associated with PD.
Nevertheless, SH-SY5Y is a neuroblastoma cell line, rather than a neuronal cell line. Although it has some neuronal phenotypes, it is often differentiated with retinoic acid or brain derived neuronal factor for neuroscience studies. So, I am wondering, whether it would be possible to do the same mutation on differentiated SH-SY5Y cells. Thus, the results would be more robust and the conclusion can be better proved. Anyway, to use the cells at a passage below 10 is perfect. High passage number can dramatically change the phenotype of SH-SY5Y cells. Most of the scientists may neglect this, but this manuscript has paid enough attentions on the passage number.
Secondly, the association between rotenone and oxidative stress is not perfectly proved yet. Although there are some studies using rotenone to induce oxidative stress model in the study of PD, rotenone is actually a mitochondrial complex 1 blocker. Most of the studies may use H2O2 to mimic the oxidative stress (Murtaza et al., 2016) . Of course, the blockade of complex 1 in mitochondria will change the cellular respiration. But, such a change might be the reduction of O2 consumption (Nichols et al., 2015) . So, if it is believed that the cell death induced by rotenone is through oxidative stress, it would be ideal that some data or references can be given to demonstrate such an assumption.
Moreover, this manuscript has mentioned 'ER', without giving the full name of it. My understanding is that 'ER' is the abbreviation of endoplasmic reticulum. Is it correct? If yes, ER is definitely playing an important role in neuronal death and neuroprotection. However, this manuscript has not given full explanation regarding to how ER is involved in this model and the neuroprotective effect of genistein here. Actually, the activation of ER may further induce Ca2+ release from ER, as ER is the intracellular Ca2+ pool, which may further enhance the Ca2+ overload in neurons. Thus, the ER activation is often a negative thing in neuroprotection. So, if the ER activation is positive here, it is expected that which part of ER is activated and how such an activation may protect neurons from oxidative stress.
In summary, the topic itself is important and relevant new. But, the data on differentiated SH-SY5Y cells, the background infromation of rotenone with oxidative stress, and the mechanism of how neurons may be protected through ER activation are expected within the major revision, before this manuscript is published.
